Koers CNS RESP OTC Bulletin Board
Aandelen
CNSOD
US12619C2008
Biotechnologie & Medisch Onderzoek
Omzet 2021 | 20,61 mln. 19 mln. | Omzet 2022 | 18,39 mln. 16,96 mln. | Marktkapitalisatie | 12,9 mln. 11,89 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -15 mln. -13,83 mln. | Nettowinst (verlies) 2022 | -10 mln. -9,22 mln. | EV/omzet 2021 | 4,97 x |
Nettoschuld 2021 | 20,13 mln. 18,56 mln. | Nettoschuld 2022 | 28,8 mln. 26,55 mln. | EV/omzet 2022 | 2,27 x |
K/w-verhouding 2021 |
-5,16
x | K/w-verhouding 2022 |
-1,21
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 48,23% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
George Sekulich
PSD | President | 59 | 01-05-19 |
Willis Lee
CHM | Chairman | 64 | 17-07-19 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 01-05-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 71 | 17-07-19 |
Willis Lee
CHM | Chairman | 64 | 17-07-19 |
Ian Zwicker
BRD | Director/Board Member | 77 | 17-07-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 54,64 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+0,04% | 12,16 mld. | |
+25,12% | 12,21 mld. | |
+26,04% | 11,94 mld. |